The members of the Management and Therapy Subcommittee undertook an evidence-
based review of current dry eye therapies and management options. Management options …

Over 70% of Americans take some form of dietary supplement every day, and the
supplement industry is currently big business, with a gross of over $28 billion. However …

Background Warfarin is a highly efficacious oral anticoagulant, but its use is limited by a well-
founded fear of bleeding. Drug and food interactions are frequently cited as causes of …

Aims To present an updated overview on the safety of concurrent use of food, herbal or
dietary supplement and warfarin. Methods A systematic literature review was performed on 5 …

Objective: To determine if the available data support the use of omega-3 essential fatty acids
(EFA) for clinical use in the prevention and/or treatment of psychiatric disorders. Participants …

Observational studies have linked lower levels of omega-3 (n-3) polyunsaturated fatty acids
(PUFAs) with inflammation and depression. This study was designed to determine whether n …

Background Polyunsaturated fatty acid (PUFA) supplements, involving omega‐3 and/or
omega‐6 components, have been proposed as a therapy for dry eye. Omega‐3 PUFAs exist …

Oral anticoagulants (OACs) are medications commonly used in patients with atrial fibrillation
and other cardiovascular conditions. Both warfarin and direct oral anticoagulants are …

To evaluate the pharmacokinetics and adverse effects of medicinal herbs, as well as clinical
evidence of herb-drug interactions. Electronic searches were conducted in multiple …

Despite its complex pharmacokinetic and pharmacodynamic profile, warfarin is still one of
the most widely used oral anticoagulant agents. Attaining optimal anticoagulation with this …